Publikationen (42) Publikationen von Jesús Manuel González Santiago

filter_list

2025

  1. Characterizing Hepatitis Delta in Spain and the gaps in its management

    Gastroenterologia y Hepatologia, Vol. 48, Núm. 2

  2. Delphi consensus statement for the management of delayed post-polypectomy bleeding

    Therapeutic Advances in Gastroenterology, Vol. 18

  3. Evolving epidemiology of HCC in Spain

    JHEP Reports, Vol. 7, Núm. 5

  4. Isolated IgG elevation in patients with persistently normal transaminases does not affect the outcome of autoimmune hepatitis

    JHEP Reports, Vol. 7, Núm. 11

  5. Management of Helicobacter pylori Infection in Spain Beyond the Data Collected in the European Registry on H. pylori Management (Hp-EuReg): Results of a Nationwide Survey

    Helicobacter, Vol. 30, Núm. 2

  6. Occurrence and Management of Opportunistic Infections in Patients With Autoimmune Hepatitis: A Spanish Multicentre Study

    Alimentary Pharmacology and Therapeutics, Vol. 62, Núm. 5, pp. 493-503

2024

  1. Effectiveness of Helicobacter pylori Treatments According to Antibiotic Resistance

    American Journal of Gastroenterology, Vol. 119, Núm. 4, pp. 646-654

  2. Impact of liver diseases and pharmacological interactions on the transportome involved in hepatic drug disposition

    Biochemical Pharmacology, Vol. 228

  3. Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir

    Alimentary Pharmacology and Therapeutics, Vol. 60, Núm. 2, pp. 201-211

  4. Spontaneously ruptured hepatocellular carcinoma on non-cirrhotic liver: A prospective case series

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 7, pp. 683-690

2023

  1. Bismuth quadruple three-in-one single capsule three times a day increases effectiveness compared with the usual four times a day schedule: results from the European Registry on Helicobacter pylori Management (Hp-EuReg)

    Gut, Vol. 72, Núm. 11, pp. 2031-2037

  2. Empirical rescue treatment of Helicobacter pylori infection in third and subsequent lines: 8-year experience in 2144 patients from the European Registry on H. pylori management (Hp-EuReg)

    Gut, Vol. 72, Núm. 6, pp. 1054-1072

  3. Splenosis as an incidental finding in a patient with multifactorial anemia

    Revista espanola de enfermedades digestivas, Vol. 115, Núm. 4, pp. 188-189

2022

  1. Beneficial effect of ursodeoxycholic acid in patients with acyl-CoA oxidase 2 (ACOX2) deficiency–associated hypertransaminasemia

    Hepatology, Vol. 76, Núm. 5, pp. 1259-1274

  2. Effectiveness and Safety of High-Dose Dual Therapy: Results of the European Registry on the Management of Helicobacter pylori Infection (Hp-EuReg)

    Journal of Clinical Medicine, Vol. 11, Núm. 12

  3. Efficacy and safety of cold versus hot snare polypectomy for small (5-9mm) colorectal polyps: A multicenter randomized controlled trial

    Endoscopy, Vol. 54, Núm. 1, pp. 35-44

  4. Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg)

    Clinical Gastroenterology and Hepatology, Vol. 20, Núm. 10, pp. 2243-2257

  5. Location, morphology and invasiveness of lateral spreading tumors in the colorectum differ between two large cohorts from an eastern and western country

    Gastroenterologia y Hepatologia, Vol. 45, Núm. 6, pp. 440-449

  6. Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study

    Liver International, Vol. 42, Núm. 8, pp. 1891-1901

  7. Radioembolisation with 90Y radiolabelled microspheres of hepatic tumour lesion with double aberrant vascular supply. Safe and easy treatment in the same operation

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 41, Núm. 2, pp. 110-112